Search Results - "IKEMATSU, HIDEYUKI"
-
1
Baloxavir Marboxil for Prophylaxis against Influenza in Household Contacts
Published in The New England journal of medicine (23-07-2020)“…In a randomized, double-blind trial that treated household contacts of patients with influenza with a single dose of baloxavir or placebo, participants taking…”
Get full text
Journal Article -
2
Effect of seasonal vaccination on the selection of influenza A/H3N2 epidemic variants
Published in Vaccine (05-01-2017)“…Highlights • The effect of vaccination on the dynamics of influenza viruses remains unknown in humans. • Our study showed higher mutations within epitopes in…”
Get full text
Journal Article -
3
Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza
Published in Expert review of anti-infective therapy (01-10-2011)“…Oseltamivir and zanamivir are well-established and well-researched drugs for the treatment of influenza in Japan and the rest of the world. A new neuraminidase…”
Get more information
Journal Article -
4
High genetic stability in MDCK-SIAT1 passaged human influenza viruses
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-03-2019)“…MDCK-induced amino acid (AA) mutation, such as D151G/N in the neuraminidase (NA) of influenza A/H3N2 viruses, is of concern. MDCK-SIAT1 cells, modified…”
Get full text
Journal Article -
5
Is seasonal vaccination a contributing factor to the selection of influenza epidemic variants?
Published in Human vaccines & immunotherapeutics (04-03-2018)“…Influenza A/H3N2 viruses are the most common and virulent subtypes for humans. Antigenic drift, changes in antigenicity through the accumulation of mutations…”
Get full text
Journal Article -
6
Consecutive influenza surveillance of neuraminidase mutations and neuraminidase inhibitor resistance in Japan
Published in Influenza and other respiratory viruses (01-03-2019)“…Background The large consumption of neuraminidase inhibitors (NAIs) for the treatment of influenza virus infections places Japan at risk of becoming the…”
Get full text
Journal Article -
7
Spread of predominant neuraminidase and hemagglutinin co-mutations in the influenza A/H3N2 virus genome
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-03-2018)“…Genetic variation of influenza neuraminidase (NA), unlike for hemagglutinin (HA), has not been fully characterized. Therefore, we determined the relation…”
Get full text
Journal Article -
8
Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection
Published in PloS one (25-07-2022)“…Waning humoral immunity after mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a significant problem for public health…”
Get full text
Journal Article -
9
Correlation of patient symptoms with SARS-CoV-2 Omicron variant viral loads in nasopharyngeal and saliva samples and their influence on the performance of rapid antigen testing
Published in Microbiology spectrum (09-10-2024)“…Evaluating SARS-CoV-2 viral loads in nasopharyngeal (NP) and saliva samples, factors affecting viral loads, and the performance of rapid antigen testing (RAT)…”
Get full text
Journal Article -
10
Post-vaccination antibody evaluation for nosocomial SARS-CoV-2 delta variant breakthrough infection
Published in PloS one (13-07-2022)“…Waning humoral immunity after mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a significant problem for public health…”
Get full text
Journal Article -
11
A randomized, controlled trial comparing traditional herbal medicine and neuraminidase inhibitors in the treatment of seasonal influenza
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-08-2012)“…Abstract The herbal medicine, maoto, has been traditionally prescribed to patients with influenza in Japan. To better understand the efficacy of maoto for the…”
Get full text
Journal Article -
12
Genetic testing and serological screening for SARS-CoV-2 infection in a COVID-19 outbreak in a nursing facility in Japan
Published in BMC infectious diseases (15-03-2021)“…The Pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has critically impacted the spread of…”
Get full text
Journal Article -
13
In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2018–19 season: Comparison with the 2010–11 to 2017–18 seasons
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-08-2020)“…To assess the extent of susceptibility to the four most commonly used neuraminidase inhibitors (NAIs) of the epidemic viruses in the 2018-19 Japanese influenza…”
Get full text
Journal Article -
14
Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate for influenza treatment; comparison among the four Japanese influenza seasons from 2011-2012 to 2014-2015
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-09-2016)“…Abstract The duration of fever and other symptoms as markers of the clinical effectiveness of laninamivir octanoate hydrate (laninamivir) were investigated in…”
Get full text
Journal Article -
15
Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate: A study of the 2017/18 and 2018/19 seasons and comparison with the 2011/12 to 2016/17 Japanese influenza seasons
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-07-2022)“…Large scale investigation of the clinical effectiveness of neuraminidase inhibitors for circulating influenza viruses are important along with the surveillance…”
Get full text
Journal Article -
16
In vitro neuraminidase inhibitory activities of four neuraminidase inhibitors against influenza viruses isolated in the 2010–2011 season in Japan
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-08-2012)“…Abstract The half maximal inhibitory concentration (IC50 ) of four neuraminidase inhibitors (NAIs), oseltamivir, zanamivir, laninamivir, and peramivir; was…”
Get full text
Journal Article -
17
In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of the influenza virus circulating in the Japanese 2013–2014 season
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-09-2015)“…Abstract To assess the extent of viral resistance, we measured the 50% inhibitory concentration (IC50 ) of neuraminidase inhibitors (NAIs) for the influenza…”
Get full text
Journal Article -
18
Duration of fever and other symptoms after the inhalation of laninamivir octanoate hydrate; comparison of the 2011/12 to 2015/16 Japanese influenza seasons
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-09-2017)“…The duration of fever and symptoms after laninamivir octanoate hydrate (laninamivir) inhalation were investigated in the Japanese 2015/16 influenza season, and…”
Get full text
Journal Article -
19
In vitro neuraminidase inhibitory activity of four neuraminidase inhibitors against clinical isolates of influenza virus in the Japanese 2012–2013 season
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-01-2015)“…Abstract The neuraminidase inhibitors (NAIs) oseltamivir phosphate (Tamiflu® ), zanamivir (Relenza® ), laninamivir octanoate (Inavir® ), and peramivir…”
Get full text
Journal Article -
20
In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017–18 season: Comparison with the 2010–11 to 2016–17 seasons
Published in Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (01-08-2019)“…To assess the extent of susceptibility to the four most commonly used neuraminidase inhibitors (NAIs) of the viruses epidemic in the 2017-18 Japanese influenza…”
Get full text
Journal Article